Kiora Pharmaceuticals' KIO-300 Shows Promise in Suppressing Seizure Activity in Preclinical Epilepsy Model

Kiora Pharmaceuticals announced that its ion channel modulator, KIO-300, significantly suppressed seizure-associated electrophysiological activity in ...